NCT02325466View on ClinicalTrials.gov

Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
Peripheral Artery DiseaseType 2 Diabetes
Interventions
DRUG

Aspirin

Aspirin 81mg

DRUG

Ticagrelor

ticagrelor 90 mg

DRUG

Aspirin Placebo

DRUG

Ticagrelor Placebo

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02325466 - Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter